Impact of Copy Number Alterations in Non-Small Cell Lung Cancer
Author Information
Author(s): Huang Yen-Tsung, Lin Xihong, Chirieac Lucian R., McGovern Ray, Wain John C., Heist Rebecca S., Skaug Vidar, Zienolddiny Shanbeh, Haugen Aage, Su Li, Christiani David C.
Primary Institution: Harvard School of Public Health
Hypothesis
Are genes with copy number changes functionally clustered in non-small cell lung cancer?
Conclusion
Copy number alterations increase with disease progression and are both positionally and functionally clustered.
Supporting Evidence
- Copy number alterations were found to be significantly higher in tumor samples compared to non-involved tissues.
- Late-stage tumors exhibited more copy number gains than early-stage tumors.
- Functional clustering of genes with copy number alterations was observed in specific biological pathways.
Takeaway
This study found that changes in the DNA of lung cancer cells increase as the disease gets worse, and these changes often happen in groups that affect similar functions.
Methodology
Genome-wide copy number analyses were performed using a dense single nucleotide polymorphism array on tumor samples, paired blood samples, and adjacent normal tissue samples.
Limitations
The study could not collect CNAs data from normal subjects or patients without lung cancer, which may provide better insights.
Participant Demographics
Patients with non-small cell lung cancer, including late-stage tumors.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website